Researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application ...
Hyundai Bioscience will begin a clinical trial with Seoul National University Hospital to identify the cause of drug resistance raised during prostate cancer treatment. Hyundai Bioscience said on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results